Liu L, Zhang F, Niu D, Guo X, Lei T, Liu H
Clin Exp Med. 2024; 24(1):214.
PMID: 39249157
PMC: 11384644.
DOI: 10.1007/s10238-024-01455-4.
Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y
J Pharm Anal. 2024; 14(7):100947.
PMID: 39149142
PMC: 11325817.
DOI: 10.1016/j.jpha.2024.02.001.
Ling Z, Yang L
Biomark Med. 2024; 18(8):419-431.
PMID: 39041844
PMC: 11285352.
DOI: 10.2217/bmm-2024-0087.
Sadeghi M, Lotfi M, Soltani N, Farmani E, Fernandez J, Akhlaghitehrani S
Cancer Cell Int. 2023; 23(1):284.
PMID: 37986065
PMC: 10661689.
DOI: 10.1186/s12935-023-03133-z.
Sell M, Ramlogan-Steel C, Steel J, Dhungel B
Expert Rev Mol Med. 2023; 25:e14.
PMID: 36927814
PMC: 10407223.
DOI: 10.1017/erm.2023.7.
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the -ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells.
Vad-Nielsen J, Staunstrup N, Kjeldsen M, Dybdal N, Flandin G, De Stradis C
Transl Lung Cancer Res. 2023; 12(1):42-65.
PMID: 36762066
PMC: 9903082.
DOI: 10.21037/tlcr-22-507.
Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.
Fariha A, Hami I, Tonmoy M, Akter S, Al Reza H, Bahadur N
Heliyon. 2022; 8(10):e11081.
PMID: 36303933
PMC: 9593298.
DOI: 10.1016/j.heliyon.2022.e11081.
The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer.
Szczyrek M, Bitkowska P, Jutrzenka M, Milanowski J
J Pers Med. 2022; 12(8).
PMID: 36013176
PMC: 9410235.
DOI: 10.3390/jpm12081227.
MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.
Konoshenko M, Lansukhay Y, Krasilnikov S, Laktionov P
Int J Mol Sci. 2022; 23(14).
PMID: 35886942
PMC: 9321818.
DOI: 10.3390/ijms23147594.
Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer Detection.
Bahado-Singh R, Vlachos K, Aydas B, Gordevicius J, Radhakrishna U, Vishweswaraiah S
Front Oncol. 2022; 12:790645.
PMID: 35600397
PMC: 9114890.
DOI: 10.3389/fonc.2022.790645.
MicroRNA-200a-3p and GATA6 are abnormally expressed in patients with non-small cell lung cancer and exhibit high clinical diagnostic efficacy.
Yu J, He X, Fang C, Wu H, Hu L, Xue Y
Exp Ther Med. 2022; 23(4):281.
PMID: 35317445
PMC: 8908458.
DOI: 10.3892/etm.2022.11210.
Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver.
Pandit A, Begum Y, Saha P, Srivastava A, Swarnakar S
Front Oncol. 2022; 11:720622.
PMID: 35145899
PMC: 8821656.
DOI: 10.3389/fonc.2021.720622.
MiR-4521 plays a tumor repressive role in growth and metastasis of hepatocarcinoma cells by suppressing phosphorylation of FAK/AKT pathway via targeting FAM129A.
Ayesha M, Majid A, Zhao D, Greenaway F, Yan N, Liu Q
J Adv Res. 2022; 36:147-161.
PMID: 35127170
PMC: 8799875.
DOI: 10.1016/j.jare.2021.05.003.
Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer.
Yang C, Hu L, Huang Z, Deng L, Guo W, Liu S
PLoS One. 2021; 16(12):e0260720.
PMID: 34855841
PMC: 8639052.
DOI: 10.1371/journal.pone.0260720.
Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands.
Hassanein S, Ibrahim S, Abdel-Mawgood A
Int J Mol Sci. 2021; 22(22).
PMID: 34830377
PMC: 8621388.
DOI: 10.3390/ijms222212496.
Knockdown of circ‑PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR‑429/FOXK1 signaling axis.
Cao L, Zhou X, Ding X, Gao D
Mol Med Rep. 2021; 24(4).
PMID: 34328193
PMC: 8365593.
DOI: 10.3892/mmr.2021.12323.
ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
Li Y, Fei H, Lin Q, Liang F, You Y, Li M
Oncogene. 2021; 40(32):5131-5141.
PMID: 34211089
PMC: 8363099.
DOI: 10.1038/s41388-021-01913-3.
Non-coding RNA in cancer.
Yan H, Bu P
Essays Biochem. 2021; 65(4):625-639.
PMID: 33860799
PMC: 8564738.
DOI: 10.1042/EBC20200032.
A KRAS-responsive long non-coding RNA controls microRNA processing.
Shi L, Magee P, Fassan M, Sahoo S, Leong H, Lee D
Nat Commun. 2021; 12(1):2038.
PMID: 33795683
PMC: 8016872.
DOI: 10.1038/s41467-021-22337-3.
MiR-200a with CDC7 as a direct target declines cell viability and promotes cell apoptosis in Wilm's tumor via Wnt/β-catenin signaling pathway.
Liang X, Wang Y, Wang P
Mol Cell Biochem. 2021; 476(6):2409-2420.
PMID: 33599894
DOI: 10.1007/s11010-021-04090-9.